Devonian Health Group, Inc. (TSE:GSD) has released an update.
Devonian Health Group Inc. is set to partake in Renmark’s Virtual Non-Deal Roadshow Series on June 26, 2024, where it will showcase its latest investor presentation and engage in a live Q&A session. The event, to be attended by the company’s CEO Luc Gregoire, is open for registration to interested stakeholders and investors. Devonian, a botanical pharmaceutical firm focused on developing treatments for inflammatory autoimmune diseases, emphasizes its efficient FDA-supported drug development strategy and commercial ventures in cosmeceuticals and pharmaceuticals in Canada.
For further insights into TSE:GSD stock, check out TipRanks’ Stock Analysis page.
